Docebo posts Q3 2025 interim financial 6-K

Docebo Inc. filed a Form 6-K as a foreign private issuer to furnish its latest interim information to U.S. investors.

Rhea-AI Filing Summary

Docebo Inc. filed a Form 6-K as a foreign private issuer to furnish its latest interim information to U.S. investors. The report packages unaudited condensed consolidated interim financial statements and management’s discussion and analysis for the three and nine months ended September 30, 2025, giving a detailed view of the company’s third-quarter 2025 performance and financial condition.

The filing also includes a press release titled “Docebo Reports Third Quarter 2025 Results,” CEO and CFO interim filing certificates under Canadian regulations, and full Inline XBRL data files for electronic analysis. Together, these materials provide a comprehensive update on Docebo’s Q3 2025 operations, governance sign-offs, and structured financial disclosures.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Docebo Inc. (DCBO) report in this November 2025 Form 6-K?

The Form 6-K from Docebo Inc. furnishes unaudited condensed consolidated interim financial statements and management’s discussion and analysis for the three and nine months ended September 30, 2025, along with related supporting documents.

Which third-quarter 2025 documents for Docebo Inc. (DCBO) are included in this 6-K?

The report includes Q3 2025 unaudited interim financial statements, Q3 2025 MD&A, and a press release titled “Docebo Reports Third Quarter 2025 Results,” plus CEO and CFO interim filing certificates and Inline XBRL files.

Are Docebo Inc.’s CEO and CFO certifications included in this 6-K filing?

Yes. The filing includes Form 52-109F2 certificates of interim filings by the CEO and the CFO, provided pursuant to Canadian regulations.

How does this Docebo Inc. (DCBO) 6-K interact with existing registration statements?

The filing specifies that Exhibits 99.1, 99.2, 99.4 and 99.5 are incorporated by reference into Docebo’s existing registration statements on Forms F-10, S-8 and F-3.

What XBRL information does Docebo Inc. provide in this Form 6-K?

Docebo includes a full Inline XBRL set: instance document, taxonomy schema, calculation, definition, label and presentation linkbases, plus a cover page interactive data file.

Whose signature appears on this Docebo Inc. Form 6-K?

The Form 6-K is signed on behalf of Docebo Inc. by Brandon Farber, who is identified as Chief Financial Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/07/2025 - 07:24 AM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025

Commission File Number 001-39750

DOCEBO INC.

(Exact name of Registrant as specified in its charter)

N/A

(Translation of Registrant’s name)

366 Adelaide St. West

Suite 701

Toronto, Ontario, Canada M5V 1R7

(800) 681-4601

(Address and telephone number of registrant’s principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☐ Form 40-F ☒

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

INCORPORATION BY REFERENCE

Exhibits 99.1, 99.2, 99.4 and 99.5 of this Form 6-K are incorporated by reference to the registrant's Registration Statement on Form F-10 (File No. 333-251046), the registrant’s Registration Statement on Form S-8 (File No. 333-251417) and the registrant’s Registration Statement on Form F-3 (File No. 333-262000).

DOCUMENTS INCLUDED AS PART OF THIS REPORT

Exhibit
99.1			Unaudited Condensed Consolidated Interim Financial Statements of Financial Position of the Registrant for the Three and Nine Months Ended September 30, 2025
99.2			Management’s Discussion and Analysis of Financial Condition and Results of Operations of the Registrant for the Three and Nine Months Ended September 30, 2025
99.3			Press Release of Docebo Inc., dated November 7, 2025, titled “Docebo Reports Third Quarter 2025 Results”
99.4			Docebo Inc. – Form 52-109F2 Certificate of Interim Filings by CEO (pursuant to Canadian regulations)
99.5			Docebo Inc. – Form 52-109F2 Certificate of Interim Filings by CFO (pursuant to Canadian regulations)
101.INS			Inline XBRL Instance Document.
101.SCH			Inline XBRL Taxonomy Schema Linkbase Document.
101.CAL			Inline XBRL Taxonomy Calculation Linkbase Document.
101.DEF			Inline XBRL Taxonomy Definition Linkbase Document.
101.LAB			Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE			Inline XBRL Taxonomy Presentation Linkbase Document.
104			Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Docebo Inc.

Date:

November 7, 2025

By:

/s/ Brandon Farber

Name:

Brandon Farber

Title:

Chief Financial Officer